Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Don’t Panic-Sell Yet: 5 Altcoins Worth Risking Before the Massive 2026 Altseason Surge

Don’t Panic-Sell Yet: 5 Altcoins Worth Risking Before the Massive 2026 Altseason Surge

CryptonewslandCryptonewsland2026/09/06 21:24
By:Cryptonewsland
  • BNB remains a large-cap altcoin closely tied to the broader BNB Chain ecosystem.
  • ALGO, QUBIC, and TIA provide exposure to different blockchain infrastructure themes.
  • PEPE carries higher sentiment-driven risk because of its memecoin structure.

Investors are keenly observing the market for altcoins for any indications of a revival of momentum in the cryptocurrency market. Following this period of volatility in the price, investors have turned their focus to other asset classes based on their use cases, network activity, and market structure. 

Some of the tokens that could gain more momentum in the event of increased altcoin liquidity include BNB, Algorand, Pepe, Qubic, and Celestia. But their perspectives are still subject to market conditions, Bitcoin dominance, liquidity streams, and investor risk appetite. 

If there’s a good altcoin cycle to come, then not all tokens would necessarily be better off. Instead, there can be a rotation of capital from large-cap networks to established blockchain projects, speculative memecoins, emerging infrastructure projects, etc. This makes the notion of selectivity significant as traders draw near the subsequent move in the crypto market for 2026. 

BNB Remains a Large-Cap Altcoin to Watch

BNB is among the bigger assets on the altcoin market. It has a strong correlation with the overall BNB Chain ecosystem activity and the overall sentiment of major crypto markets. If market liquidity improves, large-cap assets may receive consideration before smaller tokens. BNB should therefore be added to traders’ watchlists when there is a major trend change in the market towards altcoins.

Algorand Faces a Different Market Setup

Algorand represents a distinct segment of the market, with a focus on blockchain infrastructure and network development.

Its position could become more relevant if investors begin favoring established blockchain networks over purely speculative assets. Network activity and developer adoption would remain important factors for evaluating that thesis.

Pepe Adds a Higher-Risk Component

Pepe occupies a different category because its market behavior is heavily influenced by memecoin sentiment. During periods of strong risk appetite, memecoins can experience sharp changes in trading activity. However, the same characteristic can increase downside risk when market sentiment weakens.

Qubic and Celestia Offer Infrastructure Exposure

Qubic and Celestia provide exposure to different areas of blockchain infrastructure. Qubic has drawn attention around decentralized computing and network development, while Celestia focuses on modular blockchain infrastructure.

Their performance could depend more heavily on adoption, ecosystem growth, and broader demand for blockchain infrastructure. Those factors may develop differently from memecoin trends.

What Could Define the Next Altcoin Move?

The next major altcoin rotation could depend on market breadth rather than individual token narratives. Falling Bitcoin dominance, stronger altcoin volume, and improving liquidity could provide broader support.

Still, traders would need to distinguish between temporary rallies and sustained trends. BNB, ALGO, PEPE, QUBIC, and TIA therefore represent different risk profiles rather than a single investment category.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23

Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market

Eli Lilly is collaborating with Hims & Hers Health, leveraging the telehealth company’s large customer base to expand access to its blockbuster weight loss drugs and boost sales of medications, including its new oral weight loss drug Foundayo.

智通财经•2026/11/06 12:37
Eli Lilly (LLY.US) "lowers its stance" and joins forces with former rival Hims (HIMS.US) to compete for the self-pay weight loss drug market